Patent · US Active

Pharmaceutical powder compositions

US8710028B2 · kind B2 · utility

2Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 29, 2008
Grant dateApr 29, 2014
Priority date
Expiry dateAug 29, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A powder composition for intranasal delivery includes a benzodiazepine drug and chitosan, a salt of chitosan, a derivative of chitosan or a salt of a derivative of chitosan.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.